Voya Financial delivered a strong performance in 2025, exceeding targets with over $1 billion in pretax adjusted operating earnings and a 22% increase in EPS to $8.85. The company generated $775 million in excess capital, surpassing its $700 million target, driven by record flows in Retirement ($28 billion) and Investment Management ($15 billion), which pushed total assets under management/administration past $1 trillion. While the Retirement and Investment Management segments showed robust margin expansion (40% adj. margin in Retirement) and record revenues, the Employee Benefits segment faced headwinds in Stop Loss, necessitating a $37 million reserve increase in Q4 despite securing a 24% rate increase for the January 2026 cohort. Management remains confident heading into 2026, prioritizing share repurchases ($150 million planned for Q1 and Q2) and further margin improvement in Stop Loss.
| Metric | Value | Change |
|---|---|---|
| EPS (2025) | $8.85 | +22% |
| Adj. Operating Earnings | >$1 Billion | +$168M YoY |
| Excess Capital (2025) | $775 Million | Above $700M Target |
| Adjusted ROE | 18.6% | +200 bps |
| Retirement Earnings | ~$1 Billion | +17% |
| Retirement Margin | 40% | Stable/High |
| DC Net Flows | $28 Billion | Record High |
| IM Net Revenue | >$1 Billion | Record High |
| IM Organic Growth | 4.8% | Above 2% Target |
| Stop Loss Loss Ratio | 84% | -10 pts (from 94%) |
| Jan 2026 Rate Increase | 24% | N/A |
Voya is aggressively deploying capital towards share repurchases, signaling confidence in valuation and cash flow. The company plans to repurchase $150 million in Q1 2026 and expects to repeat this in Q2. With an adjusted ROE of 18.6% (up 200+ bps), management views buybacks as the most value-accretive use of capital near-term, though they remain open to M&A opportunities similar to the successful OneAmerica acquisition.
The Retirement segment is demonstrating durable commercial momentum with record organic defined contribution net flows of $28 billion and a participant base approaching 10 million. The integration of OneAmerica has significantly exceeded financial targets, adding $60 billion in assets and generating over 30% unlevered returns. This scale reinforces the 'integrated business model' and supports a 40% adjusted operating margin.
In Investment Management, Voya is achieving diversification and scale, with record net revenues exceeding $1 billion and 4.8% organic growth. The firm is strategically positioned in high-growth areas like private assets and insurance asset management. The realization of $35 million in performance fees in Q4 indicates strong investment performance, which is a key driver for future flows.
Management is actively re-pricing and tightening risk selection in the Stop Loss business to restore margins. Securing a 24% rate increase for the January 2026 cohort (up from 21% the prior year) while maintaining in-force premiums demonstrates pricing power in a high-demand, low-supply market. This strategic pivot aims to offset a '20% high teens' loss cost trend driven by specialty drugs and cancer frequency.
Voya is leveraging AI to drive efficiency and client experience rather than viewing it solely as a disruption risk. Management noted AI deployment in claims and contact centers to support margins. Additionally, CIO Matt Toms highlighted that the company's general account has minimal exposure to volatile tech debt (<1%), positioning them to withstand tech sector volatility better than peers.
The Stop Loss segment remains a significant area of concern and uncertainty. Despite a 10-point improvement in the full-year loss ratio (94% to 84%), the company took a $37M reserve charge in Q4. Management admitted the 'range of outcomes' is 'double the normal range' due to healthcare inflation, making it difficult to model future profitability with precision.
Analysts expressed skepticism regarding the transparency of Stop Loss claims data. Multiple questions focused on the discrepancy between management's assertion that the 2025 book is 'modestly better' than 2024 and the decision to build reserves. The refusal to provide specific paid claims data until Q1 adds to the opacity, potentially eroding trust in the segment's turnaround story.
The healthcare backdrop is described as 'once-in-a-generation,' driven by high-frequency cancer claims and expensive cell/gene therapies. While Voya is securing rate increases, the severity and frequency of these claims (e.g., 'younger ages') could outpace pricing if the trend accelerates beyond the 'high teens' percentage currently forecasted.
The Voluntary and Employee Benefits margins face pressure from a strategic shift toward customer value. Management indicated a 'modest increase' in loss ratios for Voluntary products (to ~50%) is part of the plan to drive retention and bundle with leave offerings, which could dampen margin expansion in the near term.
Overall: Management exhibited a high level of confidence regarding the core Retirement and Investment Management franchises, frequently using terms like 'exceptional,' 'record,' and 'strong momentum.' However, the tone shifted to defensive and cautious when addressing Stop Loss reserves and claims trends, where they emphasized prudence and 'disciplined' risk management over immediate profitability to reassure skeptical analysts.
Confidence: HIGH/MEDIUM - Confidence is HIGH regarding the core business (Retirement/IM) and capital generation, but MEDIUM regarding the near-term trajectory of Stop Loss due to the 'once-in-a-generation' healthcare backdrop and wider ranges of outcomes.
$150 million in Q1 2026 and expected $150 million in Q2 2026.
Expect further excess capital improvement in 2026.
Actions (pricing, risk selection, reserving) support further margin expansion in 2026.
Anticipate meaningful defined contribution net inflows in 2026, back-half weighted.
On track to deliver another year of organic growth above 2% long-term target.
Hedging & Uncertainty: Management utilized significant hedging language specifically regarding the Stop Loss segment to manage expectations. Phrases like 'range of outcomes is wider,' 'prudent to be on the higher end of that best estimate range,' and 'modestly better' were used to describe the 2025 book performance. This hedging reveals a lack of precision in their reserving models due to the volatile healthcare environment. In contrast, language regarding Retirement and Investment Management was definitive, using terms like 'record,' 'exceptional,' and 'exceeded targets,' highlighting a clear dichotomy in confidence between the business units.
The range of outcomes today is different than what I would say historically... probably double the normal range. - Michael Katz, CFO
We have our arms around this... Absolutely, we do. - Michael Katz, CFO
We aren't declaring victory. - Heather Lavallee, CEO
We feel like as we move forward on the progress of margin improvement... we're going to have even more opportunity in 2026. - Michael Katz, CFO
Don't conflate where we're reserved at with where this ultimately lands. - Michael Katz, CFO
We're pricing this business... to get our target margins. - Michael Katz, CFO
Analyst Sentiment: Analysts were highly focused and somewhat skeptical regarding the Stop Loss segment, pressing repeatedly for clarity on reserve adequacy and paid claims data. Questions on other segments were more standard, focusing on growth drivers and capital allocation.
Management Responses: Management remained consistent and disciplined in their responses regarding Stop Loss, refusing to be pinned down on specific paid claims numbers while insisting they have 'their arms around the situation.' They were more open and enthusiastic when discussing Retirement and Investment Management performance.
Stop Loss Reserves: Analysts sought to understand if the $37M reserve build was due to adverse development or conservatism. Management emphasized it was prudence given a 'wider range of outcomes.'
Stop Loss Pricing/Trend: Discussion centered on whether the 24% rate increase was sufficient to cover the '20% high teens' medical trend. Management confirmed they are pricing to target margins.
Capital Deployment: Questions focused on the balance between buybacks and M&A. Management prioritized buybacks near-term but left the door open for strategic acquisitions.
AI Impact: Analysts asked about opportunities and risks (disintermediation). Management highlighted AI as an efficiency tool and noted low exposure to tech debt in their investment portfolio.
Voya Financial is executing well on its core strategy, evidenced by record flows in Retirement, robust growth in Investment Management, and a 22% increase in EPS. The company's capital position is strong, with an 18.6% ROE and a clear commitment to returning capital via buybacks ($300M+ planned for first half of 2026). While the Stop Loss segment introduces volatility and requires close monitoring due to healthcare inflation, management's decisive pricing actions (24% rate hike) and risk selection improvements provide a path to margin recovery. The valuation appears attractive given the double-digit earnings growth and capital return profile, making the risk/reward favorable for long-term investors.
Management is experiencing a 'once-in-a-generation' healthcare backdrop characterized by 'high single-digit, maybe 10% first dollar trend' which leverages to 20%+ in Stop Loss. Drivers include higher cancer frequency at younger ages and high severity from cell and gene therapies.
The retirement industry is in a period of 'secular consolidation.' Voya views itself as a 'natural buyer' following the successful integration of OneAmerica, though they currently prioritize buybacks over M&A due to high hurdles for value accretion.
Voya sees AI as a tool for efficiency and client experience (opportunity) but acknowledges potential disruption risks. They are mitigating investment risk by keeping tech exposure in their general account low (<1%).